Intercytex launches Cell2Therapy service

Intercytex has a broad experience in developing Cell Therapies and bringing them to the clinic.  We have been approached by several groups in order to assist with their projects which has led Intercytex to develop our Cell2Therapy service.  The goal of Cell2Therapy is to help clients in ALL steps to bring autologous or allogeneic cell therapies through the clinic from product development, obtaining clinical approvals (including CMC), to GMP manufacture of the investigational product and the clinical trials themselves.


More details can be found

E-mail Print PDF